文献速递关节外科骨质疏松与代谢性骨病

估算肾小球滤过率对全髋关节置换术后30天死亡率及并发症的影响:一种风险分层工具

Effects of Estimated Glomerular Filtration Rate on 30-Day Mortality and Postoperative Complications After Total Hip Arthroplasty: A Risk Stratification Instrument.
PubMed 文献 · J Arthroplasty · 2019-10-09

本研究基于美国外科质量改进计划数据库2008至2016年间101,925例初次全髋关节置换术,分析估算肾小球滤过率(eGFR)与30天结局的关系。结果显示eGFR<30 mL/min/1.73 m2时死亡和非家庭出院风险增加,eGFR<60 mL/min/1.73 m2时主要和次要并发症风险增加,且eGFR与结局呈非线性关系。作者建议将eGFR作为筛查工具用于术前风险咨询。

要点

  • eGFR<30 mL/min/1.73 m2与全髋置换术后30天死亡和非家庭出院风险增加相关。
  • eGFR<60 mL/min/1.73 m2与主要和次要并发症(如输血、心肌梗死)风险增加相关。
  • eGFR与死亡率及并发症呈非线性关系,低于60后风险呈指数上升。

核心结论

  • 低eGFR患者,尤其是eGFR<30 mL/min/1.73 m2者,更易发生内科并发症,死亡率是正常eGFR者的6至9倍。
  • 全髋关节置换术合并慢性肾病患者应使用eGFR作为筛查工具进行术后并发症风险咨询。

研究设计与样本

  • 采用多因素回归模型调整人口学和合并症差异,并用多因素样条回归评估eGFR连续变量与结局的非线性关系。

主要发现

  • eGFR降至<30 mL/min/1.73 m2时死亡和非家庭出院风险增加(P < .05)。
  • eGFR<60 mL/min/1.73 m2时任何主要并发症、任何次要并发症及输血、心肌梗死等特定并发症风险增加(P < .05)。
  • eGFR与死亡(P = .0001)、主要并发症(P < .001)、次要并发症(P < .001)及非家庭出院(P < .001)呈非线性关系。
  • eGFR<60 mL/min/1.73 m2后,死亡、主要并发症和次要并发症风险呈指数增加;例如死亡率在<15 mL/min/1.73 m2或透析时增加900%,15至30 mL/min/1.73 m2时增加600%,30至60 mL/min/1.73 m2时增加50%。

关键数值与推荐

  • eGFR<30 mL/min/1.73 m2:死亡和非家庭出院风险增加(P < .05)。
  • eGFR<60 mL/min/1.73 m2:任何主要并发症、任何次要并发症及输血、心肌梗死等特定并发症风险增加(P < .05)。
  • eGFR<60 mL/min/1.73 m2后风险指数上升:死亡率增加幅度为<15 mL/min/1.73 m2或透析900%、15-30 mL/min/1.73 m2 600%、30-60 mL/min/1.73 m2 50%。

临床怎么用

  • 全髋关节置换术前可使用eGFR进行风险分层,识别高危患者。
  • 对eGFR<30 mL/min/1.73 m2患者应充分告知死亡和非家庭出院风险。
  • 对eGFR<60 mL/min/1.73 m2患者应告知主要和次要并发症风险增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease (CKD) is a relatively common comorbidity that has been shown to adversely affect outcomes in total hip arthroplasty (THA), as well as to increase the procedure's total costs. However, the effect of different stages of kidney disease and the association of estimated glomerular filtration rate (eGFR) with perioperative THA complications are less understood. Therefore, the aims of this study were to investigate the relationships between eGFR, both as a categorical and continuous variable and 30-day outcomes and complications. METHODS: The National Surgical Quality Improvement Program database was used to identify 101,925 primary THAs between January 1, 2008, and December 31, 2016. The following outcomes were assessed: 30-day mortality, 30-day major complications, 30-day minor complications, specific complications, and discharge disposition. To evaluate the effect of eGFR status on outcomes and complication, multivariate regression models were created to adjust for differences in patient demographics and comorbidities. In addition, multivariate spline regressions were developed to assess the nonlinear relationships between eGFR as a continuous variable and the outcomes of interest. RESULTS: Our study revealed that as eGFR decreases to <30 mL/min/1.73 m2, there is an increased risk for mortality and nonhome discharge (P < .05). There was an increased risk for any major complication and any minor complication as well as several specific medical complications such as transfusion and myocardial infarction (P < .05) for an eGFR of <60 mL/min/1.73 m2. Patients' eGFR had a nonlinear relationship with mortality (P = .0001), any major complication (P < .001), and any minor complication (P < .001), as well as a number of other specific medical complications. Once the eGFR, <60 mL/min/1.73 m2 the increase was exponential for mortality, major complications, and minor complications. For example, mortality increased of 900% for <15 mL/min/1.73 m2 or on dialysis, 600% for 15 to 30 mL/min/1.73 m2 and 50% for 30 to 60 mL/min/1.73 m2. Similarly, nonlinear relationships were discovered between eGFR and nonhome discharge (P < .001). CONCLUSION: Patients with lower eGFR, and in particular those with <30 mL/min/1.73 m2, are more likely to sustain medical complications and have 6 to 9 times higher mortality than patients with normal eGFR. THA patients with CKD should be appropriately counseled and advised on the risk of postoperative complications by using eGFR as a screening tool.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Warren JA, George J, Anis HK, et al. Effects of Estimated Glomerular Filtration Rate on 30-Day Mortality and Postoperative Complications After Total Hip Arthroplasty: A Risk Stratification Instrument. J Arthroplasty. 2019. PMID: 31852610. doi:10.1016/j.arth.2019.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。